Page 84 - Cronos Group News Today

These income stocks, with yields ranging from 4.4% to 10.3%, are investors' tickets to riches.

These income stocks, with yields ranging from 4.4% to 10.3%, are investors' tickets to riches.

Global Roundup: Denmark's AGC Biologics Breaks Ground on New Copenhagen Facility - read this article along with other careers information, tips and advice on BioSpace

The Fresh Toast - Cannabis and celebrities seem to go increasingly hand in hand. - Celebrity

/PRNewswire/ -- In 2020, Canada became the largest exporter of dried cannabis flower in the world. Today, Canada is looking over its shoulder at a formidable...

Sorted by valuation, the selected dividend stocks still offer only fair prices. PG stock has the highest value score, compared to the average score of 44/100. Still, all of the picks score a 75/100 or higher on quality. Investors are getting companies that offer an excellent return on invested capital, profitability, and manageable debt-to-equity. Altria Group (MO) Source: Kristi Blokhin / Shutterstock.com Juul, an e-vape firm, and a 45% stake in Cronos Group (NASDAQ: CRON). A new management t...

"It will be quite interesting if it can breach that psychological barrier in the near term," said Kevin Headland, senior investment strategist at Manulife Investment Management. The Toronto market outpaced its U.S. peers on the day, week and over the past month. The TSX climbed 1.7 per cent over the holiday-shortened week and 3.9 per cent in May with one day of trading remaining. In New York, the Dow Jones industrial average was up 64.81 points at 34,529.45 to close its month with U.S. markets ...

Cronos Group Inc.   announces that at its Annual Meeting of Shareholders held earlier today there were 430 shareholders voting in person or by proxy holding in total 280,023,803 common shares of the Company, representing 75.35% of the total number of common shares of the Company outstanding. Each of the directors listed as a nominee in the Company’s proxy statement dated April 27, 2021 was elected as a director ...

Author Bio Alex began writing for the Fool in early 2020 and follows companies in the healthcare sector. Formerly a researcher in the biotech industry, he leverages his science background in his work as a writer and entrepreneur. His interests include exploring his hometown of Boston, traveling in Latin America, and value investing. Follow @alexcarchidi The first step to making money by investing in stocks is to keep the money you already have. Thats particul...

Dividend Kings With 50+ Years Of Dividend Growth